AB-Biotics SA (CATS:ABB) announced a private placement of 500,000 shares at 2.15 per share for gross proceeds of 1,075,000 with new investor on August 7, 2013. Through the transaction, the investor will acquire more than 5% stake in the company.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% | -.--% | -.--% |
2022 | AB-Biotics, S.A. acquired Alifarm S.A. for EUR 3.5 million. | CI |
2019 | Kaneka Europe Holding Company N.V. completed the acquisition of 18.21% stake in AB-Biotics, S.A. | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 69.57M | |
-14.37% | 11.65B | |
+70.73% | 3.88B | |
-29.39% | 2.33B | |
-12.90% | 2.2B | |
+37.56% | 1.2B | |
-2.40% | 758M | |
-15.17% | 529M | |
-34.29% | 475M | |
+13.72% | 338M |
- Stock Market
- Equities
- ABB Stock
- News AB-Biotics, S.A.
- AB-Biotics SA announced that it expects to receive €1.08 million in funding.